Statins may block an inflammation pathway involved in the development of cancer

FHS
May 30, 2024
12:36 pm

A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that statins-;commonly used cholesterol-lowering drugs-;may block a particular pathway involved in the development of cancer that results from chronic inflammation.

Medication-assisted treatment training for OUD reduces bias and stigma, improves care

Medication-assisted treatment (MAT), such as naltrexone, is a well-documented successful treatment for opioid use disorder (OUD).

June 22, 2023

EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor – Biotech Investments

Pentixapharm Holding AG / Key word(s): Study EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor 18-Oct-2024 / 15:49 CET/CEST Disclosure of an inside information

October 19, 2024

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

Non-small lung cancer (NSCLC) that progressed on immunotherapy did not benefit from the combination of a PD-L1 inhibitor and a targeted agent versus chemotherapy, a

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.